Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In February, the FDA approved a new monoclonal antibody for the treatment of metastatic colorectal cancer.

Pharmacology Update: Cetuximab Injection (Erbitux)